JONATHAN HUMPHREY: Open Payments
NPI 1689644866 · DANVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,440 in 120 payments from 39 companies in 2025. Trend: 2023 $2,430 · 2024 $3,610 · 2025 $2,440
Food & beverage: $2,440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $328 |
| PFIZER INC. | 10 | $216 |
| Novo Nordisk Inc | 6 | $155 |
| GlaxoSmithKline, LLC. | 6 | $153 |
| Amgen Inc. | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| Esperion Therapeutics, Inc. | 5 | $98 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| Antares Pharma, Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
Products named: REXULTI, UBRELVY, OTEZLA, NEXLETOL, NURTEC ODT, Auvelity, XYOSTED, LEQVIO.
Industry payments across CA — which companies pay providers there.
